Versant Venture Management, LLC Repare Therapeutics Inc. Transaction History
Versant Venture Management, LLC
- $61.3 Million
- Q3 2025
A detailed history of Versant Venture Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 2,646,657 shares of RPTX stock, worth $4.37 Million. This represents 7.6% of its overall portfolio holdings.
Number of Shares
2,646,657
Previous 2,646,657
-0.0%
Holding current value
$4.37 Million
Previous $3.68 Million
26.64%
% of portfolio
7.6%
Previous 6.53%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
50Shares Held
30.3MCall Options Held
158KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$17.1 Million0.98% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.68 Million2.63% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$5.48 Million0.2% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.9 Million17.66% of portfolio
-
Redmile Group, LLC San Francisco, CA1.59MShares$2.62 Million0.31% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $69.2M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...